- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
SIFROL ER - 0.375mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N04BC05 | B | Pramipexole (dihydrochloride monohydrate) - 0.375mg | 5807 | 219497/10 | SIFROL ER | 0.375mg | 30 | Tablet, extended release | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 665,202 L.L | 23.08 | A1 | Boehringer Ingelheim International GmbH | Germany | 2/5/2024 | 0 |